Inflammation in chronic venous insufficiency. Is the problem insurmountable?

Area of Science:

• Vascular Biology
• Microcirculation Research
• Venous Disease Pathophysiology

Background:

• Elevated venous pressure is a key feature of venous insufficiency.
• Mechanisms of vascular and parenchymal cell damage in venous pressure elevation are not fully understood.
• The role of venous occlusion and flow interruption as risk factors in venous disease requires further investigation.

Purpose of the Study:

• To investigate the impact of venous occlusion and subsequent reperfusion on microvascular tissue.
• To determine the extent to which venous occlusion and flow interruption contribute to tissue damage.
• To evaluate the therapeutic potential of a micronized purified flavonoid fraction in mitigating venous occlusion-induced injury.

Main Methods:

• Occlusion of a rat mesenteric draining venule (50 micrometer) for 1 hour using a micropipette.
• Reperfusion of the occluded venule for 1 hour.
• Monitoring parenchymal cell death using propidium iodide (PI) labeling.
• Administration of a micronized purified flavonoid fraction (100 mg/kg/day) for 1 week.
• Assessment of leukocyte rolling, adhesion, and migration.

Main Results:

• Venous occlusion led to a significant increase in parenchymal cell death, primarily during reperfusion.
• Treatment with the flavonoid fraction significantly reduced parenchymal cell death.
• The flavonoid treatment also decreased leukocyte rolling, adhesion, and migration during both occlusion and reperfusion.
• Tissue damage occurred during both occlusion and reperfusion phases.

Conclusions:

• Venous occlusion combined with elevated microvascular pressure causes parenchymal cell death, even in initially symptomless tissue.
• Tissue damage occurs during both the occlusion and reperfusion periods.
• Micronized purified flavonoid fraction demonstrates a protective effect against venous occlusion-induced tissue damage and inflammation.